Tradr 2X Long Innovation ETF (NASDAQ:TARK – Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 172,000 shares, a growth of 42.0% from the November 15th total of 121,100 shares. Based on an average daily volume of 79,800 shares, the short-interest ratio is currently 2.2 days.
Hedge Funds Weigh In On Tradr 2X Long Innovation ETF
A hedge fund recently bought a new stake in Tradr 2X Long Innovation ETF stock. Western Pacific Wealth Management LP bought a new position in Tradr 2X Long Innovation ETF (NASDAQ:TARK – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 950 shares of the company’s stock, valued at approximately $62,000. Western Pacific Wealth Management LP owned approximately 0.10% of Tradr 2X Long Innovation ETF at the end of the most recent reporting period.
Tradr 2X Long Innovation ETF Stock Performance
Shares of TARK stock traded up $0.75 during trading hours on Friday, hitting $51.76. 31,164 shares of the company were exchanged, compared to its average volume of 130,980. The business’s 50-day simple moving average is $39.65 and its two-hundred day simple moving average is $33.27. Tradr 2X Long Innovation ETF has a one year low of $20.00 and a one year high of $55.61.
Tradr 2X Long Innovation ETF Company Profile
The AXS 2X Innovation ETF (TARK) is an exchange-traded fund that is based on the ARK Innovation ETF index. The fund is an actively-managed fund-of-fund that seeks to achieve 2x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions.
Recommended Stories
- Five stocks we like better than Tradr 2X Long Innovation ETF
- The How and Why of Investing in Gold Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Tradr 2X Long Innovation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tradr 2X Long Innovation ETF and related companies with MarketBeat.com's FREE daily email newsletter.